G72 gene is associated with susceptibility to methamphetamine psychosis

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 6, 2009, Pages 1046-1049

  Kotaka, Tatsuya ^a   Ujike, Hiroshi ^a,b   Okahisa, Yuko ^a   Takaki, Manabu ^a   Nakata, Kenji ^c   Kodama, Masafumi ^a   Inada, Toshiya ^b,d   Yamada, Mitsuhiko ^b,e   Uchimura, Naohisa ^b,f   Iwata, Nakao ^b,g   Sora, Ichiro ^b,h   Iyo, Masaomi ^b,i   Ozaki, Norio ^b,j   Kuroda, Shigetoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b JGIDA ^*  (Japan)

^c Takahashi Hospital   (Japan)

^d SEIWA HOSPITAL   (Japan)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^f KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Amphetamines; G30; Glutamate; Schizophrenia; Substance induced psychosis

Indexed keywords

CHROMOSOME PROTEIN; DEXTRO AMINO ACID OXIDASE; G72 PROTEIN; METHAMPHETAMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE PSYCHOSIS; PATHOGENESIS; PSYCHOSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CARRIER PROTEINS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS;

EID: 67651098835     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.05.017     Document Type: Article

References (32)

1. Addington A.M., Gornick M., Sporn A.L., Gogtay N., Greenstein D., Lenane M., et al. Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biol Psychiatry 55 (2004) 976-980
2. Badner J.A., and Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7 (2002) 405-411
3. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 99 (2002) 13675-13680
4. Coyle J.T. The GABA-glutamate connection in schizophrenia: which is the proximate cause?. Biochem Pharmacol 68 (2004) 1507-1514
5. Detera-Wadleigh S.D., and McMahon F.J. G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 60 (2006) 106-114
6. Fallin M.D., Lasseter V.K., Avramopoulos D., Nicodemus K.K., Wolyniec P.S., McGrath J.A., et al. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 77 (2005) 918-936
7. Faul F., Erdfelder E., Lang A.G., and Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39 (2007) 175-191
8. Goldberg T.E., Straub R.E., Callicott J.H., Hariri A., Mattay V.S., Bigelow L., et al. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 31 (2006) 2022-2032
9. Hall J., Whalley H.C., Moorhead T.W., Baig B.J., McIntosh A.M., Job D., et al. Genetic variation in the DAOA (G72) gene modulates hippocampal function in subjects at high risk of schizophrenia. Biol Psychiatry 64 (2008) 428-433
10. Ide S., Kobayashi H., Ujike H., Ozaki N., Sekine Y., Inada T., et al. Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms. Pharmacogenomics J 6 (2006) 179-188
11. Kishimoto M., Ujike H., Motohashi Y., Tanaka Y., Okahisa Y., Kotaka T., et al. The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biol Psychiatry 63 (2007) 191-196
12. Korostishevsky M., Kaganovich M., Cholostoy A., Ashkenazi M., Ratner Y., Dahary D., et al. Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol Psychiatry 56 (2004) 169-176
13. Kvajo M., Dhilla A., Swor D.E., Karayiorgou M., and Gogos J.A. Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Mol Psychiatry 13 (2008) 685-696
14. Ma J., Qin W., Wang X.Y., Guo T.W., Bian L., Duan S.W., et al. Further evidence for the association between G72/G30 genes and schizophrenia in two ethnically distinct populations. Mol Psychiatry 11 (2006) 479-487
15. Madeira C., Freitas M.E., Vargas-Lopes C., Wolosker H., and Panizzutti R. Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia. Schizophr Res 101 (2008) 76-83
16. Moy S.S., Perez A., Koller B.H., and Duncan G.E. Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function. Brain Res 1089 (2006) 186-194
17. Numakawa T., Yagasaki Y., Ishimoto T., Okada T., Suzuki T., Iwata N., et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 13 (2004) 2699-2708
18. Ohmori T., Abekawa T., Muraki A., and Koyama T. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine. Pharmacol Biochem Behav 48 (1994) 587-591
19. Raybould R., Green E.K., MacGregor S., Gordon-Smith K., Heron J., Hyde S., et al. Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1). Biol Psychiatry 57 (2005) 696-701
20. Reid M.S., Hsu Jr. K., and Berger S.P. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse 27 (1997) 95-105
21. Schulze T.G., Ohlraun S., Czerski P.M., Schumacher J., Kassem L., Deschner M., et al. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes. Am J Psychiatry 162 (2005) 2101-2108
22. Schumacher J., Jamra R.A., Freudenberg J., Becker T., Ohlraun S., Otte A.C., et al. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 9 (2004) 203-207
23. Shi J., Badner J.A., Gershon E.S., and Liu C. Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophr Res 98 (2008) 89-97
24. Ujike H. Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr Psychiatry Rep 4 (2002) 177-184
25. Ujike H., and Sato M. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann N Y Acad Sci 1025 (2004) 279-287
26. Ujike H., Katsu T., Okahisa Y., Takaki M., Kodama M., Inada T., et al. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis. Prog Neuropsychopharmacol Biol Psychiatry 33 (2009) 625-629
27. Wang X., He G., Gu N., Yang J., Tang J., Chen Q., et al. Association of G72/G30 with schizophrenia in the Chinese population. Biochem Biophys Res Commun 319 (2004) 1281-1286
28. Williams N.M., Green E.K., Macgregor S., Dwyer S., Norton N., Williams H., et al. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry 63 (2006) 366-373
29. Williams N.M., O'Donovan M.C., and Owen M.J. Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia?. Schizophr Bull 31 (2005) 800-805
30. Williams N.M., Preece A., Morris D.W., Spurlock G., Bray N.J., Stephens M., et al. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry 61 (2004) 336-344
31. Yue W., Kang G., Zhang Y., Qu M., Tang F., Han Y., et al. Association of DAOA polymorphisms with schizophrenia and clinical symptoms or therapeutic effects. Neurosci Lett 416 (2007) 96-100
32. Zou F., Li C., Duan S., Zheng Y., Gu N., Feng G., et al. A family-based study of the association between the G72/G30 genes and schizophrenia in the Chinese population. Schizophr Res 73 (2005) 257-261